| Institution: | 1. Cardiac MR PET CT Program, Department of Radiology (Cardiovascular Imaging) and Division of Cardiology, Massachusetts General Hospital and Harvard Medical School, 165 Cambridge Street, Suite 400, Boston, MA 02114-2750, USA;2. Department for Diagnostic and Interventional Radiology, University Hospital Frankfurt, Johann-Wolfgang-Goethe University, Theodor-Stern-Kai 7, 60590 Frankfurt/Main, Germany;3. Department of Radiology, Massachusetts General Hospital and Harvard Medical School, 55 Fruit St, Boston, MA 02114-2750, USA;1. Biomedical Imaging Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA;2. Department of Internal Medicine 2, University of Erlangen, Erlangen, Germany;3. Department of Imaging and Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA;4. Department of Cardiology, St Francis Hospital, New York, NY, USA;5. Department of Medicine, University of California at Irvine, Irvine, USA;6. Department of Radiology and Radiological Science, Medical University of South Carolina, Charleston, SC, USA;7. Division of Cardiology, Mount Sinai St Lukes Hospital, New York, NY, USA;1. The Ohio State University Davis Heart and Lung Research Institute, 473 W. 12th Ave, Columbus, OH 43210, USA;2. OSU Department of Physiology and Cell Biology, 473 W. 12th Ave, Columbus, OH 43210, USA;3. Dalio Institute for Cardiovascular Imaging, Weill-Cornell Medical Center, New York, NY 10021, USA;4. University of Maryland School of Public Health, Department of Epidemiology and Biostatistics, College Park, MD 20742, USA |
| Abstract: | BackgroundPulmonary nodules (PN) are frequently detected incidentally during coronary computed tomography angiography (CTA). We evaluated whether the 2017 Fleischner Society guidelines may result in a decrease of follow-up testing of incidental PN as compared to prior guidelines in patients undergoing coronary CTA.MethodsWe conducted a retrospective study of a registry of emergency department patients who underwent coronary CTA for acute coronary syndrome assessment between 2012 and 2017. Based on guidelines, patients <35 years, history of cancer, or prior exams showing stability of PN were excluded. Patients >60 years, history of smoking, irregular/spiculated PN morphology, or PN size >20 mm were classified as high-risk for lung cancer. Radiological findings pertaining to PN were identified (PN size, morphology, quantity) through review of radiology reports. PN follow-up recommendations were established using 2017 Fleischner Society Guidelines and compared with prior guidelines for solid (2005) and subsolid (2013) PN. Data were analyzed with Student's t-test.ResultsThe registry included 2066 patients (female 45.1%, 52.9 ± 11.0 years), of which 578 (28.0%) reported PN. 438 of those (21.2%) were eligible for guideline-based follow-up evaluation. 205 (4 6.8%) were classified as high-risk for lung cancer. 2017 guidelines reduced the number of individuals requiring follow-up by 64.5%, from 264 (12.8%) to 94 patients (4.5%) when compared to prior guidelines (p < 0.001). The minimum number of follow-up chest CTs decreased by 55.8% from 430 to 190 (p < 0.001).ConclusionApplication of the 2017 Fleischner Society Guidelines resulted in a significant decrease of follow-up testing for incidental PN in patients undergoing coronary CTA for suspected acute coronary syndrome. |
